PRAC wants change for high-dose ibuprofen

16 April 2015 - Deborah Wilkes

Archived

There is a small increase in the risk of cardiovascular problems, such as heart attacks and strokes, in people taking systemic medicines containing a high dose of ibuprofen, according to the European Union's Pharmacovigilance Risk Assessment Committee (PRAC). However, no increase in risk is seen in people taking ibuprofen at the lower doses generally used in OTC medicines.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: